Showing results (1531-1540 of 1,858) with videos related to

Sort By:
Pageof 186
Oncology Reports|November 18, 2004
Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinomaSoichiro Morinaga, Yoshiyasu Nakamura, Naoki Ishiwa, et al.
Biochemical and Biophysical Research Communications|September 30, 2022
Structure of MotA, a flagellar stator protein, from hyperthermophileTatsuro Nishikino, Norihiro Takekawa, Duy Phuoc Tran, et al.
Kidney International. Supplement|July 21, 1999
Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study GroupE Muso, M Mune, Y Fujii, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Radiofrequency ablation and percutaneous ethanol injection in patients with unresectable hepatocellular carcinoma--a comparative study using Japan Integrated Staging Score (JIS score) system]Manabu Morimoto, Kazushi Numata, Kazuya Sugimori, et al.
Journal of Agricultural and Food Chemistry|January 24, 2002
Physical, chemical, and biological properties of s-allylcysteine, an amino acid derived from garlicYukihiro Kodera, Ayumi Suzuki, Osamu Imada, et al.
Journal of Medicinal Chemistry|April 21, 2001
Synthesis, structure-activity relationships, and pharmacokinetic profiles of nonpeptidic alpha-keto heterocycles as novel inhibitors of human chymaseF Akahoshi, A Ashimori, H Sakashita, et al.
The Prostate|January 24, 2008
A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditionsKumiko Maruyama-Takahashi, Naoki Shimada, Teruyoshi Imada, et al.
Pathology International|February 12, 2025
Evaluation of NANOG/HDAC1 Expression in Predicting Outcomes of BCG Therapy in Non-Muscle Invasive Bladder CancerTakahisa Yamashita, Morihiro Higashi, Mami Yamazaki, et al.
International Journal of Clinical Oncology|April 22, 2026
Efficacy and safety of second-line fluorouracil, leucovorin, and irinotecan plus ramucirumab according to prior first-line regimens in metastatic colorectal cancer: a multicenter retrospective studyToshinori Yanagawa, Kozo Kataoka, Hiroki Osumi, et al.
Surgery Today|July 15, 2026
Sex-related differences in postoperative complications after pelvic exenteration and their relationship with surgical invasiveness in a multicenter studyKei Kimura, Masataka Igeta, Yusuke Yatabe, et al.
Pageof 186